StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Friday. The firm issued a hold rating on the stock. TherapeuticsMD Stock Performance Shares of TXMD opened at $1.81 on Friday. TherapeuticsMD has a 1 year low of $1.43 and a 1 year high of $4.35. The business has […]

Leave a Reply

Your email address will not be published.

Previous post Zai Lab (NASDAQ:ZLAB) Price Target Lowered to $38.00 at JPMorgan Chase & Co.
Next post Teradyne (NASDAQ:TER) Given New $180.00 Price Target at KeyCorp